New Consensus Recommendations Guide Sjogren’s Syndrome Management

New consensus-based recommendations from the European League Against Rheumatism (EULAR) address the management of Sjogren’s syndrome with topical and systemic therapies, according to a Reuters report.

Sjogren’s syndrome presents with a broad spectrum of clinical manifestations and autoantibodies, including antinuclear antibodies (the most frequently detected), anti-Ro/SS-A (the most specific), and cryoglobulins and hypocomplementemia (the main prognostic markers).

For decades, the management of Sjogren’s syndrome has been based on symptomatic treatment of sicca symptomatology and broad-spectrum immunosuppression for systemic disease, yet there is little information on the relative efficacy and safety of the available therapeutic options.

Read the full article.